Changeflow GovPing Pharma & Drug Safety Patent Application for Feeder Cells and Cell Sh...
Routine Notice Added Draft

Patent Application for Feeder Cells and Cell Sheet Production

Favicon for changeflow.com ChangeBridge: Patent Apps - Biotech (C12N)
Published September 6th, 2023
Detected March 27th, 2026
Email

Summary

The USPTO has published a new patent application (US20260085290A1) filed by DAI NIPPON PRINTING CO., LTD. The application details a method for producing feeder cells and cell sheets, derived from pluripotent stem cells, intended for maintaining or proliferating difficult-to-culture cells. This is a standard publication of a patent application.

What changed

This document is a publication of a patent application (US20260085290A1) filed by DAI NIPPON PRINTING CO., LTD. The application describes a novel method for producing feeder cells and cell sheets derived from pluripotent stem cells. These feeder cells are designed to facilitate the maintenance and proliferation of cells that are typically challenging to culture using standard two-dimensional methods. The invention specifically involves deriving fibroblast-like cells from an endoderm- and mesoderm-derived cell population within the intestinal structure.

As this is a patent application, it does not impose direct regulatory obligations or compliance deadlines on entities. However, it represents a new development in biotechnology that may impact intellectual property strategies for companies in the pharmaceutical, biotechnology, and medical device sectors. Companies involved in stem cell research, cell culture, or regenerative medicine should be aware of this filing for potential licensing or competitive intelligence purposes. The application was filed on September 6, 2023.

Source document (simplified)

← USPTO Patent Applications

FEEDER CELLS, CELL SHEET, PRODUCTION METHOD FOR FEEDER CELLS AND CELL SHEET, AND METHOD OF MAINTAINING OR PROLIFERATING CELLS USING FEEDER CELL

Application US20260085290A1 Kind: A1 Mar 26, 2026

Assignee

DAI NIPPON PRINTING CO., LTD.

Inventors

Kenichi MORINAGA, Akihiro UMEZAWA

Abstract

A feeder cell for maintaining or proliferating, by a two-dimensional culture, a cell deemed to be difficult to maintain and proliferate by a two-dimensional culture; and a method of producing the feeder cell. A fibroblast-like cell is produced from a pluripotent stem cell, and derived from an intestinal structure containing an endoderm-derived cell and a mesoderm-derived cell is proliferated, isolated, and used as a feeder cell.

CPC Classifications

C12N 5/0656 C12N 2502/14 C12N 2506/23 C12N 2513/00

Filing Date

2023-09-06

Application No.

19109459

View original document →

Classification

Agency
USPTO
Published
September 6th, 2023
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260085290A1

Who this affects

Applies to
Drug manufacturers Medical device makers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing 3254.1 Biotechnology
Activity scope
Biotechnology Research Cell Culture
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Legal
Topics
Biotechnology Intellectual Property

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Apps - Biotech (C12N) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.